EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-89
SponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

About this trial

The purpose of this research study is to evaluate the outcomes of two standard of care group exercise regimens to increase muscle mass in women who have been treated with breast cancer.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Women with a biopsy proven diagnosis of ductal carcinoma in situ or invasive carcinoma of the breast

Women must have undergone treatment for breast cancer, including one or more of the following: surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy. Women undergoing active chemotherapy are not allowed on study. Immunotherapy or targeted agent usage is allowed.

Disqualifiers

Any current treatment with cytotoxic chemotherapy for breast cancer

Inability to safely engage in group sessions of resistance training as deemed by study PI

Severe arthritic, joint, cardiovascular, or musculoskeletal condition deemed by PI to be unsafe to engage in resistance training

Trial design

Design model

Parallel

Treatments tested in this trial

  • Control Arm ACSM Guidelines

    Other intervention

    The control group will follow resistance training guidelines from the American College of Sports Medicine. Eight to ten multi-joint exercises will be performed to stress the major muscle groups.

  • Experimental Arm 6-12-25 repetitions per set

    Other intervention

    The exercise regimens will employ a mixture of compound exercises utilizing both open and closed kinetic chain movements (CKC), focusing on exercises with the goal of increasing skeletal muscle mass and body composition. The regimen will incorporate 6, then 12, then 25 repetitions in sequence per set per muscle group with minimal amounts of rest between.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Control Arm / ACSM GuidelinesOther 1 intervention
Group B: Experimental Arm / EOC GuidelinesExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Determine changes in muscle and fat mass during and after each exercise regimen

The experimental group will follow a 6-12-25 program geared at optimizing hypertrophy and metabolism via high volume and increased time under tension.

Time frame
The exercise program will last for 8 weeks and continuously monitored by the PI and clinical team.

Secondary outcomes

1

Determine adherence defined as number of sessions attended of total sessions

The experimental group will follow a 6-12-25 program geared at optimizing hypertrophy and metabolism via high volume and increased time under tension.

Time frame
The exercise program will last for 8 weeks and continuously monitored by the PI and clinical team.
2

Determine changes in strength measured via load calculations (repetitions x sets x weight)

The experimental group will follow a 6-12-25 program geared at optimizing hypertrophy and metabolism via high volume and increased time under tension.

Time frame
The exercise program will last for 8 weeks and continuously monitored by the PI and clinical team.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.